{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:54:17Z","timestamp":1778626457673,"version":"3.51.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2018.00232","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T08:22:12Z","timestamp":1530692532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts"],"prefix":"10.3389","volume":"9","author":[{"given":"Noushin","family":"Nabavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin C.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Gout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.","volume":"13","author":"Alakus","year":"2015","journal-title":"J. Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","article-title":"A mouse model recapitulating molecular features of human mesothelioma.","volume":"65","author":"Altomare","year":"2005","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7670","DOI":"10.1073\/pnas.85.20.7670","article-title":"Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA.","volume":"85","author":"Appel","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","first-page":"495","article-title":"Biological characterization of a mesothelioma line in nude mice. I. Transplantation of in vitro cultivated cells of a human ascitic tumor effusion.","volume":"49","author":"Arnold","year":"1979","journal-title":"Arch. Geschwulstforsch."},{"key":"B5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0046-8177(82)80083-X","article-title":"Studies of a human mesothelioma.","volume":"13","author":"Behbehani","year":"1982","journal-title":"Hum. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/0019-5278.146897","article-title":"Global mesothelioma epidemic: trend and features.","volume":"18","author":"Bianchi","year":"2014","journal-title":"Indian J. Occup. Environ. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1073\/pnas.170207097","article-title":"Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.","volume":"97","author":"Bocchetta","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses.","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"B11","first-page":"181","article-title":"Transplantation of human malignant mesothelioma into nude mice.","volume":"40","author":"Chahinian","year":"1980","journal-title":"Cancer Res."},{"key":"B12","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00203","article-title":"Microenvironment-dependent phenotypic changes in a SCID mouse model for malignant mesothelioma.","volume":"3","author":"Darai-Ramqvist","year":"2013","journal-title":"Front. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.2910520609","article-title":"Establishment of a murine model of malignant mesothelioma.","volume":"52","author":"Davis","year":"1992","journal-title":"Int. J. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1014321729038","article-title":"Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium).","volume":"13","author":"Hubner","year":"2002","journal-title":"Cancer Causes Control"},{"key":"B16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1749-0774.2003.tb00157.x","article-title":"Establishment and characterization of a human malignant mesothelioma cell line (HMMME).","volume":"16","author":"Ishiwata","year":"2003","journal-title":"Hum. Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1183\/13993003.00091-2016","article-title":"Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study.","volume":"48","author":"Ji","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A conditional mouse model for malignant mesothelioma.","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod. Pathol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1362-2","article-title":"Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.","volume":"15","author":"Kalra","year":"2015","journal-title":"BMC Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/08958370600835393","article-title":"Animal models of malignant mesothelioma.","volume":"18","author":"Kane","year":"2006","journal-title":"Inhal. Toxicol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1073\/pnas.0604544103","article-title":"Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.","volume":"103","author":"Kroczynska","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","first-page":"4297","article-title":"Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.","volume":"56","author":"Lee","year":"1996","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jtcvs.2015.02.020","article-title":"Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.","volume":"149","author":"Lei","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1021\/nn402241b","article-title":"Chronic exposure to carbon nanotubes induces invasion of human mesothelial cells through matrix metalloproteinase-2.","volume":"7","author":"Lohcharoenkal","year":"2013","journal-title":"ACS Nano"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(04)17102-X","article-title":"Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids.","volume":"364","author":"L\u00f3pez-R\u00edos","year":"2004","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/srep22850","article-title":"Human malignant mesothelioma is recapitulated in immunocompetent BALB\/c mice injected with murine AB cells.","volume":"6","author":"Mezzapelle","year":"2016","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","article-title":"Absence of p53 mutations in malignant mesotheliomas.","volume":"16","author":"Mor","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B29","first-page":"544","article-title":"Biological characterization of a mesothelioma line in the nude mice. II. Some characteristics of cells cultivated in vitro prior to and after transplantation in nude mice.","volume":"49","author":"Nissen","year":"1979","journal-title":"Arch. Geschwulstforsch."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-62","article-title":"Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.","volume":"8","author":"Nymark","year":"2007","journal-title":"BMC Genomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ejcts.2007.01.047","article-title":"Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.","volume":"31","author":"Opitz","year":"2007","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3892\/ijo.18.2.425","article-title":"Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas.","volume":"18","author":"Papp","year":"2001","journal-title":"Int. J. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jcb.240630509","article-title":"In vitro and in vivo studies of mesothelioma.","volume":"24","author":"Pass","year":"1996","journal-title":"J. Cell. Biochem. Suppl."},{"key":"B34","first-page":"142","article-title":"Nonrandom chromosome alterations in human malignant mesothelioma.","volume":"48","author":"Popescu","year":"1988","journal-title":"Cancer Res."},{"key":"B35","first-page":"S51","article-title":"Gene profiling and kinase screening in asbestos-exposed epithelial cells and lungs.","author":"Ramos-Nino","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B36","first-page":"3199","article-title":"Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.","volume":"47","author":"Reale","year":"1987","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.","volume":"66","author":"Robinson","year":"2006","journal-title":"Cancer Res."},{"key":"B38","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000444445","article-title":"Benign cystic mesothelioma misdiagnosed as peritoneal carcinomatosis.","volume":"10","author":"Shin","year":"2016","journal-title":"Case Rep. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1749-6632.1991.tb24465.x","article-title":"Comparability of mesothelioma in humans and in experimental animal studies.","volume":"643","author":"Suzuki","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B41","first-page":"4349","article-title":"Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.","volume":"53","author":"Taguchi","year":"1993","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1440-1827.1995.tb03399.x","article-title":"Establishment and characterization of a new human mesothelioma cell line (T-85) from malignant peritoneal mesothelioma with remarkable thrombocytosis.","volume":"45","author":"Tange","year":"1995","journal-title":"Pathol. Int."},{"key":"B43","first-page":"4505","article-title":"A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.","volume":"58","author":"Testa","year":"1998","journal-title":"Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma.","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"B45","first-page":"369","article-title":"Cytology of experimental mesotheliomas induced with crocidolite asbestos.","volume":"31","author":"Topov","year":"1987","journal-title":"Acta Cytol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci."},{"key":"B47","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ijc.2910440212","article-title":"Establishment of human malignant mesothelioma cell lines.","volume":"44","author":"Versnel","year":"1989","journal-title":"Int. J. Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55825-7","author":"Wang","year":"2017","journal-title":"Patient-Derived Xenograft Models of Human Cancer."},{"key":"B50","first-page":"185","article-title":"Cytologic and tissue culture characteristics of asbestos-induced mesothelioma in rats.","volume":"28","author":"Whitaker","year":"1984","journal-title":"Acta Cytol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1749-6632.1958.tb54899.x","article-title":"Discussion of part VI\u2217.","volume":"76","author":"Woolley","year":"1958","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","article-title":"Patient-derived xenograft establishment from human malignant pleural mesothelioma.","volume":"23","author":"Wu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B53","first-page":"281","article-title":"Establishment and characterization of human malignant pleural mesothelioma cell line SMC-1.","volume":"28","author":"Wu","year":"1985","journal-title":"Sci. Sin. B"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1002\/ijc.25002","article-title":"An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S-1 therapy.","volume":"126","author":"Yanagihara","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.07.03","article-title":"Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.","volume":"3","author":"Zhang","year":"2015","journal-title":"Ann. Transl. Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T08:22:21Z","timestamp":1530692541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":55,"alternative-id":["10.3389\/fgene.2018.00232"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2018.00232","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"article-number":"232"}}